NCI-H1048 Cells

NCI-H1048 is a human small cell lung carcinoma (SCLC) cell line derived from a lung tumor in an adult patient and is widely used as a model of neuroendocrine lung cancer. Small cell lung carcinoma is characterized by rapid growth, early metastatic spread, and strong association with neuroendocrine differentiation, and NCI-H1048 reflects many of these features. The cells typically grow in suspension or as loosely adherent clusters and display morphology consistent with SCLC, including small, round cells with high nuclear-to-cytoplasmic ratios.

At the molecular level, NCI-H1048 exhibits features characteristic of SCLC, including alterations in key tumor suppressor pathways such as TP53 and RB1, which are commonly inactivated in this disease. The cell line expresses neuroendocrine markers, including proteins associated with hormone secretion and neuronal differentiation, making it a relevant model for studying neuroendocrine signaling and tumor biology. Like other SCLC models, it may also display amplification or overexpression of oncogenic drivers involved in proliferation and survival, contributing to its aggressive phenotype.

NCI-H1048 is used in research focused on small cell lung cancer pathogenesis, drug sensitivity, and resistance mechanisms. It is particularly valuable for evaluating chemotherapeutic agents and targeted therapies in a disease context known for initial treatment responsiveness followed by rapid relapse. The cell line is also used in studies of tumor cell plasticity, neuroendocrine differentiation, and high-throughput drug screening. However, as with many SCLC models, detailed mutation-specific profiles may vary between datasets, and additional molecular characterization is recommended for experiments requiring precise genomic information.